2024 MSK Cardio-Oncology Symposium

Thursday, May 2, 2024, 8:00 AM - Friday, May 3, 2024, 6:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

The advances in cancer therapeutics has significantly improved cancer survival. With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate 2-5 times higher mortality risk due to cardiovascular disease than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns about the cardiovascular challenges faced by patients with cancer, the field of Cardio-Oncology has evolved, consisting of experts in both cancer and cardiovascular medicine working to improve the detection, monitoring, and treatment of cardiovascular disease at each stage of the cancer care continuum. The field is rapidly growing to meet the urgent need to improve the cardiovascular health of patients with cancer.

Join us in person in New York City for this state-of-the-art, comprehensive, case-based curriculum addressing critical topics relevant to the cardiovascular health of patients with cancer and cancer survivors. Together, an interdisciplinary group, consisting of cardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world, will present the latest research and contemporary practice strategies in the prevention, early diagnosis, and management of cardiovascular disease in cancer patients and cancer survivors. The symposium will include a series of talks highlighting cutting-edge and trending subjects in the rapidly evolving field of Cardio-Oncology, ensuring that participants gain insights into the most recent advancements shaping the future of cardiovascular care for cancer patients.

This symposium will offer a forum for networking and professional collaboration. All presentations will include devoted time for interaction between audience members and presenters. Additionally, a complimentary networking reception will be held on Thursday, May 2, 2024, following the symposium, to provide an opportunity for the Cardio-Oncology community to interact and get to know each other. Please RSVP for the networking reception during registration. We hope to see you there! 

Who Should Attend

This symposium is intended for cardiologists, internists, hematologists/oncologists, advanced practice providers, nurses, housestaff and other affiliated healthcare professionals who are involved in the care of cancer patients or have an interest in the field of cardio-oncology.

Attendees are invited to join us in person at Memorial Sloan Kettering's Zuckerman Research Center for this program. A virtual streaming option is available for MSK employees only.

Online Syllabus

Registered attendees will receive access to an online syllabus after the conclusion of the overall symposium. The syllabus will include select PDFs of the faculty presentations (slides) and recordings of the lectures. The syllabus (PDFs and video recordings) will be available to attendees through December 31, 2024.

1. Describe contemporary anti-cancer treatments (such as anthracyclines, targeted therapy, immunotherapy, cellular therapy, radiation), outlining their roles in cancer therapy, mechanisms of action, cardiotoxicity profiles, and their impact on the cardiovascular system
2. Determine the strategies for monitoring and managing cardiotoxicity, identifying the evidence and the knowledge gaps
3. Explain the diagnostic and treatment strategies for cardiac amyloidosis including advances in therapy
4. Demonstrate the principles of the permissive cardiotoxicity strategy and how it applies in specific treatment scenarios
5. Summarize the appropriate use of imaging modalities in contemporary Cardio-Oncology, from guidelines to best practices
6. State the late cardiovascular sequelae of cancer treatment and the best approach to managing the cardiovascular health of adult survivors of childhood cancer
7. Illustrate the challenges of managing acute cardiovascular disease in patients during cancer treatment

Program registration includes continental breakfast, lunch, refreshment breaks, and a complimentary invitation to the networking reception. Please contact [email protected] at least one week prior to the symposium if you have any special dietary requests or require any specific accommodations.

Registration Fees

• Physicians (MDs, PhDs, and DOs): $600
• Advanced Practice Providers: $450
• Nurses and Other Healthcare Providers: $400
• Residents, Fellows, and Students: $200
• Industry Professionals: $1,050*
• MSK Employees: Complimentary

MSK Alumni and MSK Cancer Alliance Members: A discounted registration rate is offered to MSK Alumni and MSK Cancer Alliance members for all CME programs at MSK. If you belong to either of these groups, please submit your request here to receive a promotion code to be applied at registration. Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

*Industry professionals may attend CME activities at Memorial Sloan Kettering for their own education. Marketing, sales, and promotion of products and services are strictly prohibited at all MSK CME activities. Please visit our Help page for more information.

Cancellation Policy

If you wish to cancel your participation in this symposium, you must email [email protected] at least seven (7) days prior to the start of the symposium, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the symposium are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any symposium due to unforeseen circumstances. In the unlikely event we must cancel or postpone this symposium, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Please note that the early discounted rate for residents, fellows, and students is non-refundable. 

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 16.50 Medical Knowledge MOC Points in the American Board of Internal Medicine's Maintenance of Certification Assessment Recognition program; and
• 16.50 Accredited CME and Self-Assessment MOC points in the American Board of Surgery’s Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit.

Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for Symposium attendees.

Symposium Directors 

Jennifer Liu, MD
Chief, Cardiology Service
Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Dipti Gupta, MD, MPH
Associate Attending, Cardiology Service 
Program Director, Cardio-Oncology Clinical Research Fellowship
Memorial Sloan Kettering Cancer Center

 

Symposium Planning Committee 

Carol L. Chen, MD
Vice Chair, Quality Assurance
Attending, Cardiology Service
Memorial Sloan Kettering Cancer Center 

Stephanie Feldman, MD
Attending
Assistant Professor of Medicine, Division of Cardiology
New York Presbyterian/Weill Cornell Medical College

Annie Tsay, MD
Cardio-Oncology Fellow
Memorial Sloan Kettering Cancer Center 

Eileen Vella, PA-C
Advanced Practice Provider Manager
Memorial Sloan Kettering Cancer Center 

Anthony F. Yu, MD, MS
Associate Attending, Cardiology Service 
Associate Professor of Medicine 
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College 

 

Invited Symposium Faculty 

Daniel Addison, MD
Ohio State University Wexner Medical Center 
Columbus, OH

Ana Barac, MD, PhD
Inova Schar Cancer
Inova Schar Heart and Vascular
Fairfax, VA

Anne Blaes, MD, MS
University of Minnesota
Minneapolis, MN

Stephanie Dixon, MD, MPH
St. Jude Children’s Research Hospital
Memphis, TN

Michael Fradley, MD
University of Pennsylvania
Philadelphia, PA

Parag Goyal, MD
Weill Cornell Medical Center
New York, NY

Robert Harrington, MD
Weill Cornell Medical Center
New York, NY

Joerg Hermann, MD, PhD
Mayo Clinic
Rochester, MN

Kristine Jang, DO
Stony Brook Medical Center
Stony Brook, NY

Sahil Khera, MD
Mount Sinai Medical Center
New York, NY

Ninian Lang, Bsc, MB, ChB, PhD
University of Glasgow
Glasgow, Scotland

Daniel Lenihan, MD
International Cardio Oncology Society
Tampa, FL

Teresa Lopez-Fernandez, MD
La Paz University
Madrid, Spain

Joshua Mitchell, MD, MSCI
Washington University Medical Center
St. Louis, MO

Babak Navi, MD, MS
Weill Cornell Medical Center
New York, NY

Tomas Neilan, MD, MPH
Massachusetts  General Hospital
Boston, MA

Jayant Raikhelkar, MD
Columbia University Irving Medical Center
New York, NY

Marielle Scherrer-Crosbie, MD, PhD
University of Pennsylvania
Philadelphia, PA

Paaladinesh Thavendiranathan, MD, SM, FRCPC, FASE
Peter Munk Cardiac Center, Toronto General Hospital
Toronto, Ontario, Canada

Jonathan Weinsaft, MD
Weill Cornell Medical Center
New York, NY

MSK Symposium Faculty 

Angel T. Chan, MD, PhD
Cardiology

Paul Cohen, MD, PhD
Cardiology

Chau T. Dang, MD, MPH
Breast Oncology

Sergio A. Giralt, MD
Bone Marrow Transplant

Michelle N. Johnson, MD, MPH
Cardiology

Ioanna Kosmidou, MD, PhD
Cardiology

Andrew Laccetti, MD
GU Oncology

Heather J. Landau, MD
Myeloma Service

Avi Leader, MD
Benign Hematology

Eileen P. McAleer, MD
Cardiology

Diana Roth O’Brien, MD, MPH
Radiation Oncology

Michael Postow, MD
Melanoma

Sofia Romero-Velez, PA-C
Advanced Practice Provider 

Wendy L. Schaffer, MD, PhD
Cardiology

Jessica Scott, PhD
Exercise Oncology

Roni Shouval, MD, PhD
Bone Marrow Transplant

Dylana Smith, AGPCNP-BC
Advanced Practice Provider 

Richard M. Steingart, MD
Cardiology

Helena A. Yu, MD
Thoracic Oncology

Jeffrey Zwicker, MD
Benign Hematology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Memorial Sloan Kettering is pleased to announce that the following company will be exhibiting during this symposium: 
Alexion, Rare Disease Company of AstraZeneca
ATTR Division, AstraZeneca
Cardiovascular, AstraZeneca
GE Healthcare
Lantheus
Oncology, AstraZeneca
Pie Medical Imaging / Esaote
Pfizer Oncology 
Pfizer Rare Disease
Philips Healthcare